July 26, 2012, Taipei

A-Spine received regulatory approval from Dept of Health, Taiwan to market Viscoseal, a hyaluronan preparation from TRB CHEMEDICA, Germany.

Viscoseal is currently the first and the only hyaluronan product with approved indications for relief of pain and promotion of joint recovery following arthroscopy or joint lavage. Clinical studies confirm Viscoseal promotes pain relief, reduces swelling and improves function in patients recovering from arthroscopy.

A-Spine signed an Agreement with TRB CHEMEDICA, Switzerland in 2008 for the exclusive distribution of Viscoseal in Taiwan. Viscoseal, the first non-spine product for A-Spine, will be commercially launched in this September.

 

 


January 2, 2012, Taipei

A-Spine Asia (ASA) entered into an agreement with Chindex Medical Limited (CML) of Beijing, China for the distribution of ASA’s SmartLoc® Advanced Spinal Fixation System and Vigor PEEK Interbody Fusion Cages in China.

The Distribution Agreement was jointly signed on Dec. 29, 2011 at FosunPharma headquarters in Shanghai by Mr. Ding Xiaojun, CEO of CML and Mr. David Chang, President of ASA.

 

 

About Chindex Medical Ltd. (CML)

CML, a joint venture company of Chindex International Inc. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd., is a leading supplier of medical equipments with more than 1,500 employees worldwide and headquartered in USA and China. For further information about CML and FosunPharma, you may visit the websites at www.chindexmedical.com and/or www.fosunpharma.com.

 

About A-Spine Asia Co., Ltd. (ASA)

ASA, a private-owned medical device company based in NeiHu Technology Park, Taipei, is a leading manufacturer of spinal implants and instruments. Smartloc®, a top-loading screw / rod spinal fixation system developed by ASA received FDA 510(k) clearance in 2011. Vigor® PEEK Interbody Fusion Cages, cervical and lumabr are made from PEEK-OPTIMA® of Invibio USA. These two products have already been approved by China SFDA and will be officially launched in China by CML during second quarter of 2012. For further information about ASA, please visit www.aspine.com.tw or by email to service@aspine.com.tw.

 

 


   

October 24, 2011, Taipei  

 A-Spine Asia Receives FDA 510(K) Clearance for SmartLoc® Spinal Fixation System

A-Spine Asia announced today that it has received 510(K) clearance from the U.S. Food and Drug Administration to market the SmartLoc® Spinal Fixation System.

It is the first product from A-Spine Asia receiving 510(K) clearance.

SmartLoc® is a top-loading pedicle screw spinal fixation system intended to provide immobilization and stabilization of thoracic, lumbar, and sacral spinal segments as an adjunct to fusion.

Since its official launch in 2006 till now, more than 20,000 procedures have been performed with this system in Taiwan. For further information about SmartLoc® and other products from A-Spine Asia please visit www.aspine.com.tw or directly contact A-Spine Asia by email to service@aspine.com.tw.


October 9, 2009, Taipei 

Clinical report for Latero PEEK--Fusion Rate of A Novel LumbarInterbody Fixation Device: Intravertebral Plate and Cage Sytem

 


August 24, 2009, Taipei  

A-Spine Asia receives DOH approval to market the Segmental Spinal Correction System (SSCS), a dynamic stabilization system from Ulrich Medical, Germany (www.ulrichmedical.com).

This unique dynamic system will be officially launched in January 2010. . A-Spine Asia is the exclusive distributor in Taiwan for the spinal implants from Ulrich Medical.

 

 


July 8, 2009, Taipei  

A-Spine Asia receives DOH approval to market geneX Putty, a newly developed bone graft with 510(k) clearance from Biocomposites, UK (www.biocomposites.com). A-Spine Asia is the exclusive distributor in Taiwan for the synthetic bone graft products from Biocomposites.

 

 

 


 

Medical Congress and Exhibition Calendar 2008

 

Visit us at any of these upcoming Spine Meetings and Conventions

continue to read ...

 

 

 


  October 11, 2007

A-Spine Asia wins Taipei Biotechnology Award Again

 A-Spine Asia wins 2007 Taipei-Bio Bronze Medal Award in the category of “Commercialization” with a cash prize of NT$400,000.- (equivalent to US$12,300).
continue to read ...

 



Medical Congress and Exhibition Calendar 2007

 

Visit us at any of these upcoming Spine Meetings and Conventions

continue to read ...

 

 

 


  December 1, 2006, Taipei 

A-Spine Asia received marketing approval from Dept. of Health (DOH) in Taiwan for the imported products Add & AddPlus from Ulrich Medical, Germany.

As the exclusive distributor for Ulrich Medical, A-Spine Asia is planning to officially launch Add/AddPlus in Taiwan in January 2007. VBR, another product from Ulrich will be launched soon after receiving DOH’s approval.

 


February 1, 2006, Taipei 

A-Spine Asia entered into an exclusive distribution agreement with Biocomposites UK for bone graft products in Taiwan.

Based on this agreement, Biocomposites’ products Stimulan, GeneX, Allogran-N and Allogran-R will be launched in Taiwan in second half of 2006.

 

 


February 26, 2004, Taipei 

 

A-Spine Asia obtained ISO9001/13485 and “CE” Marking approvals for Spinal Fixation, Metal Disc Spacer, Polymer Disc Spacer, and Instruments for Spinal Surgery.

 

 


 

December 15, 2003, Taipei

 

A-Spine Asia obtained cGMP (Currently Good Manufacturing Practice) and various product registration approvals from Department of Health in Taiwan.